{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:24:20Z","timestamp":1790429060464,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jcv.2015.09.014","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T17:17:35Z","timestamp":1445275055000},"page":"S14-S21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":154,"special_numbering":"S1","title":["VALGENT: A protocol for clinical validation of human papillomavirus assays"],"prefix":"10.1016","volume":"76","author":[{"given":"Marc","family":"Arbyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Depuydt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Benoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Bogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Cuschieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pawlita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan","family":"Geraets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Heard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik","family":"Gheit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Tommasino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Poljak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Bonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Quint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2015.09.014_bib0005","article-title":"IARC Monographs on the evaluation of carcinogenic risks to humans","volume":"vol. 90","author":"IARC Monograph Working Group","year":"2007"},{"key":"10.1016\/j.jcv.2015.09.014_bib0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol."},{"issue":"Suppl. 5","key":"10.1016\/j.jcv.2015.09.014_bib0015","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding HPV testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2015.09.014_bib0020","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"issue":"Suppl. 5","key":"10.1016\/j.jcv.2015.09.014_bib0025","doi-asserted-by":"crossref","first-page":"F100","DOI":"10.1016\/j.vaccine.2012.04.105","article-title":"Nucleic acid tests for the detection of human papillomaviruses","volume":"30","author":"Poljak","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2015.09.014_bib0030","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2015.09.014_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2015.04.015","article-title":"Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?","author":"Arbyn","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jcv.2015.09.014_bib0040","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jcv.2015.09.014_bib0045","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication","volume":"128","author":"Li","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2015.09.014_bib0050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.virol.2013.07.015","article-title":"A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types","volume":"445","author":"Bzhalava","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.jcv.2015.09.014_bib0055","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.4424","article-title":"Are twenty human papillomavirus types causing cervical cancer","volume":"234","author":"Arbyn","year":"2014","journal-title":"J. Pathol."},{"key":"10.1016\/j.jcv.2015.09.014_bib0060","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/AOG.0000000000000669","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening interim clinical guidance","volume":"125","author":"Huh","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jcv.2015.09.014_bib0065","series-title":"Human Papillomavirus Laboratory Manual","author":"Unger","year":"2010"},{"key":"10.1016\/j.jcv.2015.09.014_bib0070","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/annonc\/mdp471","article-title":"European guidelines for quality assurance in cervical cancer screening: second edition\u2014summary document","volume":"21","author":"Arbyn","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jcv.2015.09.014_bib0075","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pvr.2015.06.006","article-title":"European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination","volume":"1","author":"von Karsa","year":"2015","journal-title":"Papillomavir. Res."},{"key":"10.1016\/j.jcv.2015.09.014_bib0080","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1515\/cclm.2011.835","article-title":"High-throughput detection, genotyping and quantification of the human papillomavirus using real-time PCR","volume":"50","author":"Micalessi","year":"2012","journal-title":"Clin. Chem. Lab Med."},{"key":"10.1016\/j.jcv.2015.09.014_bib0085","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1128\/JCM.01231-12","article-title":"Clinical validation of a type-specific real time quantitative human papillomavirus PCR to the performance of hybrid capture 2 for the purpose of cervical cancer screening","volume":"50","author":"Depuydt","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.09.014_bib0090","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1128\/JCM.02227-07","article-title":"Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers","volume":"46","author":"Schmitt","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.09.014_bib0095","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/1055-9965.EPI-12-1067","article-title":"Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions","volume":"22","author":"Schmitt","year":"2013","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.jcv.2015.09.014_bib0100","first-page":"101","article-title":"HPV DNA detection and typing in cervical scrapes","volume":"119","author":"Snijders","year":"2005","journal-title":"Methods Mol. Med."},{"issue":"Suppl. 3","key":"10.1016\/j.jcv.2015.09.014_bib0105","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S1386-6532(09)70297-5","article-title":"High-throughput genotyping of high-risk HPV by the digene HPV genotyping LQ test using GP5+\/6+-PCR and xMAP technology","volume":"46","author":"Geraets","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2015.09.014_bib0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/JCM.00991-09","article-title":"Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay","volume":"48","author":"Schmitt","year":"2010","journal-title":"J. Clin. Microbiol."},{"issue":"003","key":"10.1016\/j.jcv.2015.09.014_bib0115","first-page":"1","article-title":"Clinical validation of the BD Onclarity\u2122 HPV assay using a non-inferiority test","volume":"S3","author":"Ejegod","year":"2014","journal-title":"J. Med. Microbiol. Diagn."},{"key":"10.1016\/j.jcv.2015.09.014_bib0120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1309\/AJCP4Q0NSDHWIZGU","article-title":"Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population","volume":"143","author":"Castle","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jcv.2015.09.014_bib0125","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1128\/JCM.01743-09","article-title":"Comparison of the clinical performance of PapilloCheck human papillomavirus detection with that of the GP5+\/6+-PCR-enzyme immunoassay in population-based cervical screening","volume":"48","author":"Hesselink","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.09.014_bib0130","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1128\/JCM.01962-14","article-title":"Clinical evaluation of a GP5+\/6+-based Luminex assay having full high-risk HPV genotyping capability and an internal control","volume":"52","author":"Geraets","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.09.014_bib0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2217\/fvl.11.131","article-title":"Highlights of the 27th International Papillomavirus Conference and Clinical Workshop (Berlin, 17\u201322 September 2011)-Part 2: Applied Clinical Science","volume":"7","author":"Arbyn","year":"2012","journal-title":"Future Virol."},{"key":"10.1016\/j.jcv.2015.09.014_bib0140","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1128\/JCM.00087-13","article-title":"Multiple infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities","volume":"51","author":"Schmitt","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.09.014_bib0145","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/ijc.27891","article-title":"Prevalence and viral load of 51 genital human papillomavirus types and 3 subtypes","volume":"132","author":"Schmitt","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2015.09.014_bib0150","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1128\/JCM.01366-15","article-title":"Clinical and analytical performance of the onclarity HPV assay using the VALGENT framework","volume":"53","author":"Cuschieri","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.09.014_bib0155","doi-asserted-by":"crossref","first-page":"e86835","DOI":"10.1371\/journal.pone.0086835","article-title":"Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening","volume":"9","author":"Rebolj","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2015.09.014_bib0160","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1128\/JCM.00918-10","article-title":"A global proficiency study of human papillomavirus genotyping","volume":"48","author":"Eklund","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.09.014_bib0165","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/JCM.02453-13","article-title":"Global improvement in genotyping of human papillomavirus DNA: the 2011 HPVlabnet international proficiency study","volume":"52","author":"Eklund","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2015.09.014_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1433","article-title":"The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity","volume":"201","author":"Snijders","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.jcv.2015.09.014_bib0175","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/ijc.24774","article-title":"How to evaluate emerging technologies in cervical cancer screening?","volume":"125","author":"Arbyn","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2015.09.014_bib0180","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(13)70570-9","article-title":"Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis","volume":"15","author":"Arbyn","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcv.2015.09.014_bib0185","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-1-59745-423-0_15","article-title":"Cervical cytology biobanks as a resource for molecular epidemiology","volume":"675","author":"Arbyn","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jcv.2015.09.014_bib0190","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","article-title":"Simultaneous comparison of multiple treatments: combining direct and indirect evidence","volume":"331","author":"Caldwell","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.jcv.2015.09.014_bib0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jcv.2015.09.014_bib0200","first-page":"1","article-title":"Who Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention","author":"WHO","year":"2013"},{"key":"10.1016\/j.jcv.2015.09.014_bib0205","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.jcv.2015.09.014_bib0210","series-title":"Statistical Methods for Rates and Proportions","author":"Fleiss","year":"1981"},{"key":"10.1016\/j.jcv.2015.09.014_bib0215","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/sim.1213","article-title":"On tests of equivalence via non-unity relative risk for matched-pair design","volume":"22","author":"Tang","year":"2003","journal-title":"Stat. Med."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653215006836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653215006836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T12:53:34Z","timestamp":1537275214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653215006836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":43,"alternative-id":["S1386653215006836"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2015.09.014","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VALGENT: A protocol for clinical validation of human papillomavirus assays","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2015.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}